Articles tagged "Weight"

2022 American Transplant Congress
Excessive Weight Gain Does Not Associate with Poorer Graft Outcomes in Simultaneous Pancreas-Kidney Transplant Recipients – A Single-Center Experience
N. Eleti, G. Agarwal, S. Ong, C. Kew, D. Anderson, C. Young
University of Alabama at Birmingham, Birmingham, AL
*Purpose: Weight gain is common following organ transplantation, and there exists concern that in simultaneous pancreas-kidney (SPK) recipients, this may lead to poorer graft outcomes.*Methods:…
2022 American Transplant Congress
Does Donor-to-Recipient Weight Mismatch Influence Short Term Outcomes of Deceased Donor Kidney Transplantation?
L. Sabbagh, M. Killackey, H. Jeon, K. Atiemo, A. Paramesh, A. Vijay
Tulane University School of Medicine, New Orleans, LA
*Purpose: The functional nephron mass of an allograft is often taken into consideration when contemplating transplanting a small kidney into a large recipient. We aim…
2022 American Transplant Congress
Evaluation of Different Initial Tacrolimus Dosing Regimens in Pediatric Post-Liver Transplantation
A. F. Alghanem¹, A. Alsmari¹, H. Joharji²
¹Pharmaceutical Care, King Abdulaziz Medical City, Riyadh, Saudi Arabia, ²Pharmaceutical Care, King Faisal Specialized Hospital and Research Center, Riyadh, Saudi Arabia
*Purpose: Tacrolimus is an immunosuppressant used in post-liver transplantation, has wide pharmacokinetic variability, particularly in pediatric patients. Therefore, this study aimed to evaluate different weight-based…
2022 American Transplant Congress
XR Tacrolimus Dosing By Ideal Body Weight Reduces Incidence Of Early Supratherapeutic Tacrolimus Concentrations
G. Codispodo, J. Hedvat, D. Salerno, N. Lange
Pharmacy, NewYork-Presbyterian Hospital, New York, NY
*Purpose: At our center, the use of de novo Envarsus XR® (extended-release [XR] tacrolimus) dosed at 0.12 mg/kg is standard of care in adult kidney…
2022 American Transplant Congress
Size to Fit: A Simple Formula to Predict Donor Liver Weight in Deceased Donor Liver Transplant
A. Mohamed¹, J. Cui², T. Kitajima¹, T. Shamaa¹, T. Ivanics¹, I. Godana³, A. Yorks², S. Shimada¹, B. Madek¹, M. Rizzari¹, A. Yoshida¹, M. Abouljoud¹, S. Nagai¹, K. Collins¹
¹Henry Ford Transplant Institute, Detroit, MI, ²Wayne State University School of Medicine, Detroit, MI, ³General Surgery, McLaren, Lansing, MI
*Purpose: Estimated donor liver volume (DLV) prediction equations are widely published. However, they often are complex and underpredict DLV, particularly in non-ideal body weight donors.…
2022 American Transplant Congress
BMI Trajectory and Attributable Risk of New Onset Hypertension Among Obese Living Kidney Donors
R. D. Reed¹, M. C. McLeod¹, P. A. MacLennan¹, V. Kumar¹, S. E. Brooks¹, A. G. Maynor¹, L. A. Stanford¹, G. A. Baker¹, C. A. Schinstock², J. R. Silkensen³, G. R. Roll⁴, D. L. Segev⁵, B. J. Orandi¹, C. E. Lewis⁶, J. E. Locke¹
¹Surgery, University of Alabama at Birmingham, Birmingham, AL, ²Nephrology and Hypertension, Mayo Clinic, Rochester, MN, ³Medicine, Hennepin County Medical Center, Minneapolis, MN, ⁴Surgery, University of California San Francisco, San Francisco, CA, ⁵Surgery, Johns Hopkins University, Baltimore, MD, ⁶Epidemiology, University of Alabama at Birmingham, Birmingham, AL
*Purpose: Obesity increases hypertension risk in general and living kidney donor populations. Risk attributable to donation in the context of obesity and whether that risk…
2021 American Transplant Congress
A Novel Liver Assist Device as a Bridge to Liver Transplantation in Acute on Chronic Liver Failure Patients with Multi-Organ Failure
S. Ahmad¹, I. W. Liou¹, J. Reyes², R. Bakthavatsalam³, N. C. Smith⁴, R. L. Carithers¹, C. Martin¹, D. Gao⁵
¹Medicine, University of Washington, Seattle, WA, ²Surgery, University of Washington, SEATTLE, WA, ³Surgery, University of Washington, Seattle, WA, ⁴Nursing, University of Washington, Seattle, WA, ⁵Engineering, University of Washington, Seattle, WA
*Purpose: Acute on chronic liver failure (AOCLF) occurs in nearly 25% of patients with acutely decompensated cirrhosis, with many developing multi-organ failure requiring ventilatory, vasopressor…
2021 American Transplant Congress
Attitudes of Obese Kidney Transplant Candidates Towards Bariatric Surgery
C. LaVerne, V. Thompson, G. Aguiluz, P. DiCocco, J. Almario Alvarez, M. Spaggiari, I. Tang, I. Tzvetanov, E. Benedetti
Surgery, University of Illinois Hospital & Health Sciences System, Chicago, IL
*Purpose: Obesity is an epidemic in the US and increasingly prevalent in kidney transplant candidates. Surgical weight-loss interventions are effective and reduce transplant-related complications. They…
2021 American Transplant Congress
Changes in Body Mass Index Before and After Kidney Transplant
M. Laub¹, S. Finder², P. Harikrishnan¹, M. Simon³, I. Gani¹, M. Saeed¹, R. Kapoor¹
¹Augusta University Medical Center, Augusta, GA, ²Vanderbilt University Medical Center, Nashville, TN, ³Brandon Wilde, Augusta, GA
*Purpose: Describe changes in body mass index (BMI) before and after kidney transplant and determine the association between BMI and graft loss or mortality.*Methods: Single…
2021 American Transplant Congress
Modeling of Alternative Weight-Based Dosing Strategies of LCP-Tacrolimus in De Novo Kidney Transplant Patients
J. D. Momper¹, S. J. Patel², M. A. Moten², D. R. Stevens², U. Meier-Kriesche²
¹Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, ²Medical Affairs, Veloxis Pharmaceuticals, Cary, NC
*Purpose: LCP-tacrolimus (LCPT; Envarsus XR®) is a modified-release once-daily formulation approved for prophylaxis of organ rejection in de novo kidney transplant patients in combination with…

1
2
3
…
7
Next Page »